Anavex

is a New York-based clinical-stage biopharmaceutical company that researches and develops gene-based therapies for the treatment of neurodegenerative disorders...
Read more
Anavex Interim-CEO: Terrie Kellmeyer

Interim-CEO

Terrie Kellmeyer

CEO Approval Rating

- -/100

Annual Revenue
$10.9M
Employees
40
Funding
$60.6M

Anavex Competitors

1Pfizer
2AbbVie
3Biogen
4Novartis
5GSK
6Merck
7Lilly
8Johnson & Johnson
9Roche
10Brainstorm Cell Therapeutics

Trending Companies